180 related articles for article (PubMed ID: 36515808)
1. Feasibility and safety of lateral pelvic lymph node dissection for elderly patients with middle-low rectal cancer: results of a large multicenter lateral node collaborative group study in China.
Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q
Tech Coloproctol; 2023 Aug; 27(8):655-664. PubMed ID: 36515808
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
[TBL] [Abstract][Full Text] [Related]
3. Can neoadjuvant chemoradiotherapy before lateral pelvic lymph node dissection improve local control and prognosis in rectal cancer patients with clinically suspected lateral lymph node metastasis? A multicenter lateral node study in China.
Xie Z; Chen Q; Feng B; Jiang Y; Wang X; Xing W; Liu Q;
BMC Cancer; 2024 Jan; 24(1):115. PubMed ID: 38263067
[TBL] [Abstract][Full Text] [Related]
4. Mesorectal excision with or without lateral lymph node dissection for elderly patients with mid-low rectal cancer: safety and feasibility analysis.
Zhou S; Mei S; Feng B; Yang Y; Wang X; Wang Q; Liu Q;
Jpn J Clin Oncol; 2023 Jan; 53(1):26-34. PubMed ID: 36354102
[TBL] [Abstract][Full Text] [Related]
5. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
[TBL] [Abstract][Full Text] [Related]
6. Is laparoscopic selective lateral lymph node dissection for locally advanced rectal cancer after neoadjuvant chemoradiotherapy safe?
Yang X; Gu C; Hu T; Bi L; Wei M; Deng X; Wang Z; Zhou Z
ANZ J Surg; 2019 Nov; 89(11):E492-E497. PubMed ID: 31566296
[TBL] [Abstract][Full Text] [Related]
7. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial.
Wei M; Wu Q; Fan C; Li Y; Chen X; Zhou Z; Han J; Wang Z
Trials; 2016 Nov; 17(1):561. PubMed ID: 27884204
[TBL] [Abstract][Full Text] [Related]
8. The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
Li C; Luan J; Ji X; Wang X; Li J; Li X; Zhou Y
J Surg Oncol; 2024 Feb; 129(2):273-283. PubMed ID: 37811551
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy.
Ogura A; Akiyoshi T; Nagasaki T; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Ueno M; Kuroyanagi H
World J Surg; 2017 Mar; 41(3):868-875. PubMed ID: 27730352
[TBL] [Abstract][Full Text] [Related]
10. Effective dissecting range and prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: Results of a large multicenter lateral node collaborative group in China.
Zhou S; Tang J; Liang J; Lou Z; Fu W; Feng B; Yang Y; Xiao Y; Liu Q
Front Oncol; 2022; 12():916285. PubMed ID: 36033473
[TBL] [Abstract][Full Text] [Related]
11. Establishing and validating predictive nomograms for lateral pelvic lymph node metastasis in patients with rectal cancer based on radiologic factors and clinicopathologic characteristics.
Zhou S; Yang Y; Lou Z; Liang J; Wang X; Tang J; Liu Q;
Eur J Surg Oncol; 2023 Apr; 49(4):747-754. PubMed ID: 36604232
[TBL] [Abstract][Full Text] [Related]
12. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
Kroon HM; Malakorn S; Dudi-Venkata NN; Bedrikovetski S; Liu J; Kenyon-Smith T; Bednarski BK; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Chang GJ; Sammour T
Eur J Surg Oncol; 2021 Sep; 47(9):2441-2449. PubMed ID: 34120810
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and prognostic significance of lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy for rectal patients with clinically suspected lateral lymph node metastasis.
Zhou S; Jiang Y; Pei W; Liang J; Zhou Z
BMC Surg; 2021 Dec; 21(1):441. PubMed ID: 34961494
[TBL] [Abstract][Full Text] [Related]
14. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
15. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemoradiotherapy followed by lateral pelvic lymph node dissection for rectal cancer patients: A retrospective study of its safety and indications.
Zhou S; Jiang Y; Pei W; Zhou H; Liang J; Zhou Z
J Surg Oncol; 2021 Sep; 124(3):354-360. PubMed ID: 33882149
[TBL] [Abstract][Full Text] [Related]
17. Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in rectal cancer.
Kroon HM; Hoogervorst LA; Hanna-Rivero N; Traeger L; Dudi-Venkata NN; Bedrikovetski S; Kusters M; Chang GJ; Thomas ML; Sammour T
Eur J Surg Oncol; 2022 Jul; 48(7):1475-1482. PubMed ID: 35568607
[TBL] [Abstract][Full Text] [Related]
18. Does adding lateral pelvic lymph node dissection to neoadjuvant chemotherapy improve outcomes in low rectal cancer?
Law BZY; Yusuf Z; Ng YE; Aly EH
Int J Colorectal Dis; 2020 Aug; 35(8):1387-1395. PubMed ID: 32504333
[TBL] [Abstract][Full Text] [Related]
19. Preliminary experience with lateral pelvic lymph node dissection in locally advanced rectal cancer.
Sinukumar S; Engineer R; Saklani A
Indian J Gastroenterol; 2015 Jul; 34(4):320-4. PubMed ID: 26334237
[TBL] [Abstract][Full Text] [Related]
20. Preoperative lateral lymph node features and impact on local recurrence after neoadjuvant chemoradiotherapy and total mesorectal excision for locally advanced rectal cancer: results from a multicentre international cohort study.
Achilli P; Ferrari D; Calini G; Bertoglio CL; Magistro C; Origi M; Carnevali P; Alampi BD; Giusti I; Ferrari G; Calafiore E; Spinelli A; Grass F; Deslarzes P; Hahnloser D; Abdalla S; Larson DW
Colorectal Dis; 2024 Mar; 26(3):466-475. PubMed ID: 38243617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
